|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | |
| A61P 13/12 | |||
| A61P 35/00 |
| (11) | Number of the document | 3304086 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16802790.2 |
| Date of filing the European patent application | 2016-05-27 | |
| (97) | Date of publication of the European application | 2018-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2016/002562 |
| Date | 2016-05-27 |
| (87) | Number | WO 2016/194348 |
| Date | 2016-12-08 |
| (30) | Number | Date | Country code |
| 201562167964 P | 2015-05-29 | US |
| (72) |
FUNAHASHI, Yasuhiro, JP
KADOWAKI, Tadashi, JP
|
| (73) |
Eisai R&D Management Co., Ltd.,
4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | METHOD FOR PREDICTING RESPONSIVENESS TO A COMBINATION THERAPY WITH LENVATINIB AND EVEROLIMUS |
| METHOD FOR PREDICTING RESPONSIVENESS TO A COMBINATION THERAPY WITH LENVATINIB AND EVEROLIMUS |